Patents by Inventor Pablo Vicente Escribá Ruiz
Pablo Vicente Escribá Ruiz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230097753Abstract: Described are fatty acids with one or more unsaturations, having an odd hydrocarbon chain, the fatty acids having the chemical structure of the therapeutically active metabolites of even-chain mono- or polyunsaturated alpha-hydroxylated fatty acids. Also described are compositions comprising said fatty acids, medical uses thereof, and the use thereof as indicators of the efficacy of and/or response to the treatment of a patient with the even-chain mono- or polyunsaturated alpha-hydroxylated fatty acids from which they are derived.Type: ApplicationFiled: January 28, 2021Publication date: March 30, 2023Inventors: Pablo Vicente ESCRIBÁ RUIZ, Manuel TORRES CANALEJO, Xavier BUSQUETS XAUBET, Victoria LLADÓ CAÑELLAS, Paula FERNÁNDEZ GARCÍA, Catalina Ana ROSSELLÓ CASTILLO, Sebastià PARETS BARRIOS, Roberto BETETA GOBEL, Emilce CANO URREGO, Laura ARBONA GONZÁLEZ, Raquel RODRÍGUEZ LORCA, Juan CABOT BAUZÁ, Marc MILLARES PIZÀ
-
Patent number: 11253497Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: April 22, 2020Date of Patent: February 22, 2022Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Publication number: 20200352891Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: April 22, 2020Publication date: November 12, 2020Applicant: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Patent number: 10588883Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.Type: GrantFiled: July 10, 2017Date of Patent: March 17, 2020Assignee: UNIVERSITAT DE LES ILLES BALEARSInventors: Pablo Vicente Escribá Ruiz, Xavier Busquets Xaubet, Gwendolyn Barceló Coblijn, Victoria Lladó Cañellas, Rafael Álvarez Martínez, Silvia Teres Jiménez, Daniel López, Juana Barceló Estarellas, Julian Taylor Green, Gerardo Ávila Martín
-
Publication number: 20190365690Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: December 18, 2018Publication date: December 5, 2019Applicant: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Patent number: 10201515Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: August 22, 2017Date of Patent: February 12, 2019Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 10047036Abstract: The present invention relates to hydroxy-triglycerides, their synthesis, a pharmaceutical and/or nutraceutical composition which comprises at least one of said hydroxy-triglycerides, and a method which comprises the administration to a patient of a therapeutically effective quantity of at least one of said hydroxy-triglycerides or at least one of said pharmaceutical and/or nutraceutical compositions, for the prevention and/or treatment of at least one disease selected from cancer, metabolic/cardiovascular diseases, and/or neurological/inflammatory diseases.Type: GrantFiled: October 21, 2015Date of Patent: August 14, 2018Assignee: UNIVERSITAT DE LES ILLES BALEARSInventors: Pablo Vicente Escribá Ruiz, Xavier Busquets Xaubet
-
Publication number: 20180193297Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.Type: ApplicationFiled: July 10, 2017Publication date: July 12, 2018Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Gwendolyn BARCELÓ COBLIJN, Victoria LLADÓ CANELLAS, Rafael ÁLVAREZ MARTÍNEZ, Silvia TERES JIMÉNEZ, Daniel LÓPEZ, Juana BARCELÓ ESTARELLAS, Julian TAYLOR GREEN, Gerardo ÁVILA MARTÍN
-
Publication number: 20180085332Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: August 22, 2017Publication date: March 29, 2018Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Patent number: 9907772Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: July 13, 2016Date of Patent: March 6, 2018Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Publication number: 20170313646Abstract: The present invention relates to hydroxy-triglycerides, their synthesis, a pharmaceutical and/or nutraceutical composition which comprises at least one of said hydroxy-triglycerides, and a method which comprises the administration to a patient of a therapeutically effective quantity of at least one of said hydroxy-triglycerides or at least one of said pharmaceutical and/or nutraceutical compositions, for the prevention and/or treatment of at least one disease selected from cancer, metabolic/cardiovascular diseases, and/or neurological/inflammatory diseases.Type: ApplicationFiled: October 21, 2015Publication date: November 2, 2017Applicant: Universitat de les Illes BalearsInventors: Pablo Vicente ESCRIBÁ RUIZ, Xavier BUSQUETS XAUBET
-
Patent number: 9763906Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: September 29, 2015Date of Patent: September 19, 2017Assignee: Lipopharma Therapeutics S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 9763907Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: September 29, 2015Date of Patent: September 19, 2017Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 9730906Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.Type: GrantFiled: March 20, 2015Date of Patent: August 15, 2017Assignee: UNIVERSITAT DE LES ILLES BALEARSInventors: Pablo Vicente Escribá Ruiz, Xavier Busquets Xaubet, Gwendolyn Barceló Coblijn, Victoria Lladó Cañellas, Rafael Álvarez Martínez, Silvia Teres Jiménez, Daniel López, Juana Barceló Estarellas, Julian Taylor Green, Gerardo Ávila Martín
-
Publication number: 20170035720Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: July 13, 2016Publication date: February 9, 2017Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Publication number: 20160158181Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: September 29, 2015Publication date: June 9, 2016Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Publication number: 20160158180Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: September 29, 2015Publication date: June 9, 2016Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Patent number: 9359281Abstract: This invention refers to the synthesis and purification of 2 hydroxide derivatives of fatty acids, as well as to the separation method of its enantiomers (or optic isomers) [?] y [+], to the enantiomers themselves, to pharmaceutical compositions which include them, and to their use as medicines, as well as to an in vitro method of diagnosis/prognosis and evaluation of the potential use of the molecules of the invention in different pathologies, as well as their use for the regulation of certain enzymes and the study of their activity and effects.Type: GrantFiled: October 8, 2012Date of Patent: June 7, 2016Assignee: UNIVERSITAT DE LES ILLES BALEARSInventors: Pablo Vicente Escribá Ruiz, María Laura Martín, María Antònia Noguera Salvà, Xavier Busquets Xaubet, David López Jiménez, Maitane Ibarguren Aizpitarte, José Javier Soto Salvador, Miguel Yus Astiz
-
Publication number: 20150297548Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.Type: ApplicationFiled: March 20, 2015Publication date: October 22, 2015Inventors: Pablo Vicente ESCRIBÁ RUIZ, Xavier BUSQUETS XAUBET, Gwendolyn BARCELÓ COBLlJN, Victoria LLADÓ CAÑELLAS, Rafael ÁLVAREZ MARTÍNEZ, Silvia TERES JIMÉNEZ, Daniel LÓPEZ, Juana BARCELÓ ESTARELLAS, Julian TAYLOR GREEN, Gerardo ÁVILA MARTÍN
-
Patent number: 9161928Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: March 15, 2010Date of Patent: October 20, 2015Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Silvia Teres Jimenez, Gwendolyn Barcelo Coblijn, Victoria Llado Canellas, Amaia Marcilla Etxenike, Maria Laura Martin, Monica Higuera Urbano, Rafael Alvarez Martinez, Daniel Horacio Lopez